CLINICAL_TRIALS
trial_result
· 2019-11-13
Clinical Trial Update: Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease [Phase 3]
Summary
Phase 3 trial of amantadine for gait dysfunction and freezing in Parkinson's disease was terminated with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-11-13